Amendment to the Second Point and Its Appendix of the ‘Documents to Be Submitted for Case-by-Case Review of the Use of Exosomes Derived from Human Cells in Cosmetics’, Effective from the Date of Issuance
Original source
Regulation / act修正「申請源自人體細胞之外泌體使用於化粧品之個案審查應檢送文件」第二點附表，並自即日生效。
Unlock the official file
Business Impact stays free. Paid plans unlock the original source, official text, and Regulatory Details — plus Workbench and Verify credits.
Business Impact
The Taiwan FDA has amended the required documents for case-by-case review of exosomes derived from human cells in cosmetics, effective immediately. Companies submitting such applications must follow the revised document requirements, including the updated appendix to the second point.